Gut microbiota derived short‐chain fatty acids in physiology and pathology: An update
Cell Biochemistry and Function · 2024-10 · 42 (7)
DOI: 10.1002/cbf.4108 ↗At a glance
Übersichtsarbeit in Cell Biochemistry and Function, published online on 2024-09-03. Written by Archana and 12 co-authors. Institution: Nano-Bio Laboratory, Special Centre for Nanoscience, Jawaharlal Nehru University, New Delhi, India. Major MEDLINE topics: Fatty Acids, Volatile, Gastrointestinal Microbiome. Cited 39 times so far (Crossref); 210 references. Funded by: Indian Council of Medical Research, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (original language)
Short‐chain fatty acids (SCFAs) are essential molecules produced by gut bacteria that fuel intestinal cells and may also influence overall health. An imbalance of SCFAs can result in various acute and chronic diseases, including diabetes, obesity and colorectal cancer (CRC). This review delves into the multifaceted roles of SCFAs, including a brief discussion on their source and various gut‐residing bacteria. Primary techniques used for detection of SCFAs, including gas chromatography, high‐performance gas chromatography, nuclear magnetic resonance and capillary electrophoresis are also discussed through this article. This review study also compiles various synthesis pathways of SCFAs from diverse substrates such as sugar, acetone, ethanol and amino acids. The different pathways through which SCFAs enter cells for immune response regulation are also highlighted. A major emphasis is the discussion on diseases associated with SCFA dysregulation, such as anaemia, brain development, CRC, depression, obesity and diabetes. This includes exploring the relationship between SCFA levels across ethnicities and their connection with blood pressure and CRC. In conclusion, this review highlights the critical role of SCFAs in maintaining gut health and their implications in various diseases, emphasizing the need for further research on SCFA detection, synthesis and their potential as diagnostic biomarkers. Future studies of SCFAs will pave the way for the development of novel diagnostic tools and therapeutic strategies for optimizing gut health and preventing diseases associated with SCFA dysregulation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Nano-Bio Laboratory, Special Centre for Nanoscience, Jawaharlal Nehru University, New Delhi, India.
- School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, India.
- National Institute of Immunology, New Delhi, India.
ORCID profiles: Archana
Funding
- Indian Council of Medical Research
- Department of Biotechnology, Ministry of Science and Technology, India
Cite
APA
Archana, Gupta, A. K., Noumani, A., Panday, D. K., Zaidi, F., Sahu, G. K., Joshi, G., Yadav, M., Borah, S. J., Susmitha, V., Mohan, A., Kumar, A., & Solanki, P. R. (2024). Gut microbiota derived short‐chain fatty acids in physiology and pathology: An update. Cell Biochemistry and Function, 42(7). https://doi.org/10.1002/cbf.4108
Vancouver
Archana, Gupta AK, Noumani A, Panday DK, Zaidi F, Sahu GK, et al. Gut microbiota derived short‐chain fatty acids in physiology and pathology: An update. Cell Biochemistry and Function. 2024;42(7). doi:10.1002/cbf.4108
BibTeX
@article{Archana2024,
author = {Archana and Gupta, Abhijeet Kumar and Noumani, Ashab and Panday, Dharmendra Kumar and Zaidi, Fareen and Sahu, Gaurav Kumar and Joshi, Gunjan and Yadav, Manisha and Borah, Shikha Jyoti and Susmitha, Vanne and Mohan, Anand and Kumar, Anil and Solanki, Pratima R},
title = {Gut microbiota derived short‐chain fatty acids in physiology and pathology: An update},
journal = {Cell Biochemistry and Function},
year = {2024},
volume = {42},
number = {7},
doi = {10.1002/cbf.4108}
}
EUVIMED